DBV Technologies Logo

DBV Technologies

Developing non-invasive skin patch immunotherapy for severe food allergies like peanut and milk.

DBV | PA

Overview

Corporate Details

ISIN(s):
FR0010417345 (+3 more)
LEI:
969500PVBQFWQKVDMD80
Country:
France
Address:
107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

DBV Technologies is a clinical-stage biopharmaceutical company focused on developing treatments for food allergies. The company's core technology is the proprietary Viaskin™ platform, an investigational form of epicutaneous immunotherapy (EPIT). This non-invasive patch technology is designed to deliver biologically active compounds, such as allergens, to the immune cells of the skin, thereby re-educating the immune system. DBV's development pipeline includes product candidates for common food allergies, with its lead program, Viaskin Peanut (DBV712), in late-stage clinical trials for peanut-allergic patients. Another key program is Viaskin Milk (DBV135) for milk allergies. Founded by pediatricians, the company is dedicated to improving the lives of patients with potentially life-threatening food allergies.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-14 15:44
Major Shareholding Notification
Franchissement de seuils
French 266.6 KB
2025-06-20 12:46
Major Shareholding Notification
Franchissement de seuils
French 124.2 KB
2025-06-17 16:58
Major Shareholding Notification
Franchissement de seuils
French 107.2 KB
2025-06-12 22:05
Earnings Release
DBV Technologies to Participate in Upcoming EAACI Congress 2025
English 275.8 KB
2025-06-12 22:05
Regulatory News Service
DBV Technologies participera au prochain congrès EAACI 2025
French 269.7 KB
2025-06-11 22:30
Post-Annual General Meeting Information
DBV Technologies annonce les résultats de son Assemblée Générale Mixte 2025
French 179.9 KB
2025-06-11 22:30
Declaration of Voting Results & Voting Rights Announcements
DBV Technologies Announces the Voting Results of its 2025 Combined General Meet…
English 179.7 KB
2025-06-04 22:32
Declaration of Voting Results & Voting Rights Announcements
Information Regarding the Total Number of Voting Rights and Total Number of Sha…
English 169.6 KB
2025-06-04 22:32
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total des droits de vote et d’actions composant…
French 150.3 KB
2025-06-03 22:30
Registration Form
DBV Technologies publie un amendement à son Document d’enregistrement universel…
French 178.9 KB
2025-06-03 22:30
Registration Form
DBV Technologies announces the filing of an addendum to the 2024 Universal Regi…
English 171.4 KB
2025-05-15 22:30
Pre-Annual General Meeting Information
Assemblée Générale Mixte du 11 juin 2025
French 173.8 KB
2025-05-15 22:30
Pre-Annual General Meeting Information
Combined General Meeting of June 11, 2025
English 193.4 KB
2025-05-06 22:30
Declaration of Voting Results & Voting Rights Announcements
Information regarding the total number of voting rights and  total number of s…
English 95.0 KB
2025-05-06 22:30
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total des droits de vote et d’actions composant…
French 100.7 KB

Automate Your Workflow. Get a real-time feed of all DBV Technologies filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DBV Technologies

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DBV Technologies via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2022-06-09 N/A Other Other 2,483,161 7,449,483.00 EUR

Peer Companies

Company Country Ticker View
PC İLETİŞİM VE MEDYA HİZMETLERİ SANAYİ TİCARET A.Ş. Logo
Integrated media group providing data-driven advertising and media solutions for global brands.
Türkiye PCILT
Peers Co.,Ltd. Logo
Accelerating tech adoption with consulting, HR services, and proprietary IT/AI solutions.
Japan 7066
PeptiDream Inc. Logo
Discovers peptide therapeutics via a proprietary platform and markets radiopharmaceuticals.
Japan 4587
PharmaLundensis AB Logo
Develops treatments for heavy metal toxicity and serious respiratory illnesses.
Sweden PHAL
Pharos iBio Co., Ltd. Logo
AI-powered drug development for rare and refractory diseases, focusing on oncology.
South Korea 388870
PhoenixBio Co.,Ltd. Logo
CRO providing humanized liver mouse models and testing services for preclinical drug development.
Japan 6190
P&K Skin Research Center Co.,Ltd. Logo
Clinical research for dermatological testing in cosmetics, pharma, and health food sectors.
South Korea 347740
Plantarc Bio Ltd. Logo
Developing high-yield, resilient crops via gene discovery for global seed companies.
Israel PLNT
Polymetal International plc Logo
A top global gold and silver producer with mining and exploration operations in Kazakhstan.
Kazakhstan POLY
Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France POXEL

Talk to a Data Expert

Have a question? We'll get back to you promptly.